These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 11123517)

  • 1. Increased colocalization of corticotropin-releasing factor and arginine vasopressin in paraventricular neurones of the hypothalamus in lactating rats: evidence from immunotargeted lesions and immunohistochemistry.
    Walker CD; Tilders FJ; Burlet A
    J Neuroendocrinol; 2001 Jan; 13(1):74-85. PubMed ID: 11123517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotargeted lesions of paraventricular CRF and AVP neurons in developing rats reveal the pattern of maturation of these systems and their functional importance.
    Walker CD; Tankosic P; Tilders FJ; Burlet A
    J Neuroendocrinol; 1997 Jan; 9(1):25-41. PubMed ID: 9023736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single stress induces long-lasting elevations in vasopressin mRNA levels in CRF hypophysiotrophic neurones, but repeated stress is required to modify AVP immunoreactivity.
    Aubry JM; Bartanusz V; Jezova D; Belin D; Kiss JZ
    J Neuroendocrinol; 1999 May; 11(5):377-84. PubMed ID: 10320565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of corticotropin-releasing factor and arginine vasopressin mRNA in the hypothalamus during chronic morphine treatment in rats: an in situ hybridization study.
    Laorden ML; Milanés MV; Angel E; Tankosic P; Burlet A
    J Neuroendocrinol; 2003 Jun; 15(6):586-91. PubMed ID: 12716409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of arginine vasopressin and corticotropin-releasing factor in mediating alcohol-induced adrenocorticotropin and vasopressin secretion in male rats bearing lesions of the paraventricular nuclei.
    Ogilvie KM; Lee S; Rivier C
    Brain Res; 1997 Jan; 744(1):83-95. PubMed ID: 9030416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations.
    Herman JP; Wiegand SJ; Watson SJ
    Endocrinology; 1990 Nov; 127(5):2408-17. PubMed ID: 2171915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-induced hypoglycaemia increases colocalization of corticotrophin-releasing factor and arginine vasopressin mRNAs in the rat hypothalamic paraventricular nucleus.
    Paulmyer-Lacroix O; Anglade G; Grino M
    J Mol Endocrinol; 1994 Dec; 13(3):313-20. PubMed ID: 7893349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroxine modulates corticotropin-releasing factor but not arginine vasopressin gene expression in the hypothalamic paraventricular nucleus of the developing Rat.
    Dakine N; Oliver C; Grino M
    J Neuroendocrinol; 2000 Aug; 12(8):774-83. PubMed ID: 10929090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamic and amygdaloid corticotropin-releasing hormone (CRH) and CRH receptor-1 mRNA expression in the stress-hyporesponsive late pregnant and early lactating rat.
    da Costa AP; Ma X; Ingram CD; Lightman SL; Aguilera G
    Brain Res Mol Brain Res; 2001 Jul; 91(1-2):119-30. PubMed ID: 11457499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels.
    Makino S; Smith MA; Gold PW
    Endocrinology; 1995 Aug; 136(8):3299-309. PubMed ID: 7628364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dexfenfluramine on the transcriptional activation of CRF and its type 1 receptor within the paraventricular nucleus of the rat hypothalamus.
    Laflamme N; Bovetto S; Richard D; Rivest S
    Br J Pharmacol; 1996 Mar; 117(6):1021-34. PubMed ID: 8882592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of corticotropin releasing factor (CRF), urocortin and CRF type 1 receptors in hypothalamic-hypophyseal systems under osmotic stimulation.
    Imaki T; Katsumata H; Miyata M; Naruse M; Imaki J; Minami S
    J Neuroendocrinol; 2001 Apr; 13(4):328-38. PubMed ID: 11264720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olfactory bulbectomy increases vasopressin, but not corticotropin-releasing hormone, content in the external layer of the median eminence of male rats.
    Marcilhac A; Anglade G; Hery F; Siaud P
    Neurosci Lett; 1999 Mar; 262(2):89-92. PubMed ID: 10203238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered pituitary sensitivity to corticotropin-releasing factor and arginine vasopressin participates in the stress hyporesponsiveness of lactation in the rat.
    Toufexis DJ; Tesolin S; Huang N; Walker C
    J Neuroendocrinol; 1999 Oct; 11(10):757-64. PubMed ID: 10520124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-fos mRNA pattern and corticotropin-releasing factor neuronal activity throughout the brain of rats injected centrally with a prostaglandin of E2 type.
    Lacroix S; Valliéres L; Rivest S
    J Neuroimmunol; 1996 Nov; 70(2):163-79. PubMed ID: 8898725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of an isolated arginine vasopressin (AVP) response to stress after repeated restraint: a study of both AVP and corticotropin-releasing hormone messenger ribonucleic acid (RNA) and heteronuclear RNA.
    Ma XM; Levy A; Lightman SL
    Endocrinology; 1997 Oct; 138(10):4351-7. PubMed ID: 9322950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressin and oxytocin neurones of hypothalamic supraoptic and paraventricular nuclei co-express mRNA for Type-1 and Type-2 corticotropin-releasing hormone receptors.
    Arima H; Aguilera G
    J Neuroendocrinol; 2000 Sep; 12(9):833-42. PubMed ID: 10971808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosterone differentially modulates expression of corticotropin releasing factor and arginine vasopressin mRNA in the hypothalamic paraventricular nucleus following either acute or repeated restraint stress.
    Pinnock SB; Herbert J
    Eur J Neurosci; 2001 Feb; 13(3):576-84. PubMed ID: 11168566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgens alter corticotropin releasing hormone and arginine vasopressin mRNA within forebrain sites known to regulate activity in the hypothalamic-pituitary-adrenal axis.
    Viau V; Soriano L; Dallman MF
    J Neuroendocrinol; 2001 May; 13(5):442-52. PubMed ID: 11328455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced response of the hypothalamo-pituitary-adrenal axis to alpha1-agonist stimulation during lactation.
    Windle RJ; Brady MM; Kunanandam T; Da Costa AP; Wilson BC; Harbuz M; Lightman SL; Ingram CD
    Endocrinology; 1997 Sep; 138(9):3741-8. PubMed ID: 9275060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.